| Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor NS Duesbery, CP Webb, SH Leppla, VM Gordon, KR Klimpel, ... Science 280 (5364), 734-737, 1998 | 1295 | 1998 |
| Activating mutations for the met tyrosine kinase receptor in human cancer M Jeffers, L Schmidt, N Nakaigawa, CP Webb, G Weirich, T Kishida, ... Proceedings of the National Academy of Sciences 94 (21), 11445-11450, 1997 | 538 | 1997 |
| Asbestos exposure, pleural mesothelioma, and serum osteopontin levels HI Pass, D Lott, F Lonardo, M Harbut, Z Liu, N Tang, M Carbone, C Webb, ... New England Journal of Medicine 353 (15), 1564-1573, 2005 | 483 | 2005 |
| Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium F Dieterle, F Sistare, F Goodsaid, M Papaluca, JS Ozer, CP Webb, W Baer, ... Nature biotechnology 28 (5), 455-462, 2010 | 469 | 2010 |
| The mutationally activated Met receptor mediates motility and metastasis M Jeffers, M Fiscella, CP Webb, M Anver, S Koochekpour, ... Proceedings of the National Academy of Sciences 95 (24), 14417-14422, 1998 | 298 | 1998 |
| Signaling pathways in Ras-mediated tumorigenicity and metastasis CP Webb, L Van Aelst, MH Wigler, GF Vande Woude Proceedings of the National Academy of Sciences 95 (15), 8773-8778, 1998 | 279 | 1998 |
| The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network CP Webb, CD Hose, S Koochekpour, M Jeffers, M Oskarsson, E Sausville, ... Cancer research 60 (2), 342-349, 2000 | 219 | 2000 |
| Sox2 promotes malignancy in glioblastoma by regulating plasticity and astrocytic differentiation AD Berezovsky, LM Poisson, D Cherba, CP Webb, AD Transou, ... Neoplasia 16 (3), 193-206. e25, 2014 | 190 | 2014 |
| MicroRNA 92a-2*: a biomarker predictive for chemoresistance and prognostic for survival in patients with small cell lung cancer AR Ranade, D Cherba, S Sridhar, P Richardson, C Webb, A Paripati, ... Journal of thoracic oncology 5 (8), 1273-1278, 2010 | 169 | 2010 |
| Suppression of Ras-mediated tumorigenicity and metastasis through inhibition of the Met receptor tyrosine kinase KA Furge, D Kiewlich, P Le, MN Vo, M Faure, AR Howlett, KE Lipson, ... Proceedings of the National Academy of Sciences 98 (19), 10722-10727, 2001 | 168 | 2001 |
| Identifying disease-specific genes based on their topological significance in protein networks Z Dezső, Y Nikolsky, T Nikolskaya, J Miller, D Cherba, C Webb, A Bugrim BMC systems biology 3, 1-14, 2009 | 146 | 2009 |
| Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways NS Duesbery, J Resau, CP Webb, S Koochekpour, HM Koo, SH Leppla, ... Proceedings of the National Academy of Sciences 98 (7), 4089-4094, 2001 | 146 | 2001 |
| Genes that regulate metastasis and angiogenesis CP Webb, GF Vande Woude Journal of neuro-oncology 50, 71-87, 2000 | 137 | 2000 |
| Towards consensus practices to qualify safety biomarkers for use in early drug development FD Sistare, F Dieterle, S Troth, DJ Holder, D Gerhold, ... Nature biotechnology 28 (5), 446-454, 2010 | 136 | 2010 |
| Glycogene expression alterations associated with pancreatic cancer epithelial-mesenchymal transition in complementary model systems KA Maupin, A Sinha, E Eugster, J Miller, J Ross, V Paulino, ... PloS one 5 (9), e13002, 2010 | 124 | 2010 |
| Analysis of tumor-host interactions by gene expression profiling of lung adenocarcinoma xenografts identifies genes involved in tumor formation CJ Creighton, JL Bromberg-White, DE Misek, DJ Monsma, F Brichory, ... Molecular cancer research 3 (3), 119-129, 2005 | 117 | 2005 |
| Normal and malignant prostate epithelial cells differ in their response to hepatocyte growth factor/scatter factor GA Gmyrek, M Walburg, CP Webb, HM Yu, X You, ED Vaughan, ... The American journal of pathology 159 (2), 579-590, 2001 | 107 | 2001 |
| Evidence for a role of Met-HGF/SF during Ras-mediated tumorigenesis/metastasis CP Webb, GA Taylor, M Jeffers, M Fiscella, M Oskarsson, JH Resau, ... Oncogene 17 (16), 2019-2025, 1998 | 103 | 1998 |
| Genomic events associated with progression of pleural malignant mesothelioma SV Ivanov, J Miller, R Lucito, C Tang, AV Ivanova, J Pei, M Carbone, ... International journal of cancer 124 (3), 589-599, 2009 | 91 | 2009 |
| Enhanced target gene knockdown by a bifunctional shRNA: a novel approach of RNA interference DD Rao, PB Maples, N Senzer, P Kumar, Z Wang, BO Pappen, Y Yu, ... Cancer gene therapy 17 (11), 780-791, 2010 | 83 | 2010 |
